A one day “Technical Consultation on Innovative Models for New Antibiotics’ Development and Preservation” was held at WHO headquarters on 13 May 2014. The meeting brought together leading experts to present and discuss innovative models fostering discovery and development of new antibiotics as part of the toolkit to address challenges related to antimicrobial resistance (AMR). This meeting was held in the context of the Global action plan for AMR (GAP-AMR) that WHO is mandated to develop before the next World Health Assembly. The research and development of new antimicrobials and their preservation is going to be an important pillar of the GAP-AMR.
As part of the follow-up on the Report of the WHO Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG) , the World Health Assembly, in resolution WHA66.22 and WHA decision 66(12), requested the Director-General of the WHO to “facilitate through regional consultations and broad engagement of relevant stakeholders the implementation of a few health research and development demonstration projects to address identified gaps that disproportionately affect developing countries, particularly the poor, and for which immediate action can be taken.
Increasing access to HIV treatment in middle-income countries: key data on prices, regulatory status, tariffs and the intellectual property situation
The paper provides information on the prices paid by 20 middle-income countries for adult and paediatric formulations of antiretroviral treatments recommended by WHO. It links this information with an analysis of the intellectual property situation of the selected medicines taking into account existing license agreements as well as compulsory licenses, and includes data and general information on a number of other determinants of prices and availability of ARVs, including tariffs, markups and taxes, as well as the regulatory status.
A public briefing on establishing a Global Observatory for Health Research and Development (R&D) was held by the WHO Secretariat on 6th December 2013. Developing a global health R&D Observatory is one of the actions agreed by the Member States under the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. This briefing was attended by representatives of 37 Member States, 10 civil society groups, some PDPs and funders, with a few joining via the WebEx online conference facility.